Status:
UNKNOWN
Detection of Peripheral Blood Biomarkers in Intermediate Phase Spinal Cord Injury: Correlation With Neurological and Functional Outcomes, and Comparison to Other Central and Peripheral Neurological Conditions.
Lead Sponsor:
Sheba Medical Center
Conditions:
Spinal Cord Injury
Eligibility:
All Genders
18-75 years
Brief Summary
This research looks for markers in the blood of people with spinal cord injury that may be a sign of injury severity, or serve as a clue to the degree of recovery. Investigators would also like to com...
Eligibility Criteria
Inclusion
- Diagnosis of traumatic or non-traumatic Spinal cord injury, Guillain-barre syndrome or Stroke
- No more than 3 months after injury or disease onset
- Condition severe enough to necessitate hospital/day care unit
- Signed the informed consent form
Exclusion
- Psychiatric or cognitive situations that may interfere with the trial
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01516385
Start Date
January 1 2012
Last Update
January 31 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Ramat Gan, Israel, 52620